Century Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:IPSC) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -89 M14.05 M-88.35 M-110.14 M-103.88 M -94.52 M Cash from investing activities -298.34 M-13.13 M61.13 M47.48 M107.5 M -33.04 M Cash from financing activities 417.77 M27.16 M-9.72 M74.56 M173 K 126.68 M Free cash flow -89 M14.05 M-88.35 M-110.14 M-104.72 M -95.47 M

News

Leerink reiterates Market Perform on Century Therapeutics stock

TD Cowen initiates Century Therapeutics stock rating at Buy

Oracle, Palantir among market cap stock movers on Monday

Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know

Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler

Century Therapeutics stock price target lowered to $6.60 at Clear Street

Century Therapeutics secures $135 million in private placement

FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug

Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain

Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors

Century Therapeutics appoints two new board members

Century Therapeutics stock downgraded by Leerink Partners on lack of catalysts